David A. Siegel Deciphera Pharmaceuticals, Inc. Transaction History

Two Sigma Advisers, LP

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$13.58 - $17.36 $423,696 - $541,632	-31,200 Reduced 7.22%	401,200 $6.31 Million
Q4 2023 Feb 14, 2024	BUY	$10.11 - $16.54 $2.51 Million - $4.11 Million	248,300 Added 134.87%	432,400 $6.97 Million
Q3 2023 Nov 14, 2023	SELL	$12.46 - $15.48 $1.64 Million - $2.04 Million	-131,700 Reduced 41.7%	184,100 $2.34 Million
Q2 2023 Aug 14, 2023	SELL	$13.28 - $15.96 $2.12 Million - $2.55 Million	-159,900 Reduced 33.61%	315,800 $4.45 Million
Q1 2023 May 15, 2023	BUY	$14.26 - $22.1 $799,986 - $1.24 Million	56,100 Added 13.37%	475,700 $7.35 Million
Q4 2022 Feb 14, 2023	BUY	$14.85 - $19.04 $1.69 Million - $2.16 Million	113,700 Added 37.17%	419,600 $6.88 Million
Q3 2022 Nov 14, 2022	BUY	$12.38 - $20.23 $3.04 Million - $4.97 Million	245,600 Added 407.3%	305,900 $5.66 Million
Q2 2022 Aug 15, 2022	BUY	$9.11 - $13.98 $549,333 - $842,994	60,300 New	60,300 $793,000
Q1 2021 May 17, 2021	SELL	$40.39 - $56.73 $1.97 Million - $2.77 Million	-48,804 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$51.77 - $66.18 $3.06 Million - $3.92 Million	-59,200 Reduced 54.81%	48,804 $2.79 Million
Q3 2020 Nov 16, 2020	SELL	$43.8 - $58.16 $1.62 Million - $2.15 Million	-37,000 Reduced 25.52%	108,004 $5.54 Million
Q2 2020 Aug 14, 2020	BUY	$37.05 - $65.03 $1.34 Million - $2.35 Million	36,100 Added 33.15%	145,004 $8.66 Million
Q1 2020 May 15, 2020	BUY	$33.63 - $69.4 $3.66 Million - $7.56 Million	108,904 New	108,904 $4.48 Million

343K

500

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.